Here's how a nerve-stimulation device has brought movement back to patients who are paralyzed

Feb 15, 2022

Patients were able to take their first steps within an hour of neurosurgeons first implanting prototypes of a nerve-stimulation device. Image: UNSPLASH/Chris Hardy

Ari Rabinovitch

Writer, Thomson Reuters Foundation

Our Impact

The Big Picture

Explore and monitor how Global Health is affecting economies, industries and global issues

Crowdsource Innovation

Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Global Health

A man in harness, walking whilst holding onto long handles.

'A 42-year-old patient performs training on a weight-supporting robot at Lausanne University Hospital after having received a spinal cord implant within the STIMO Bridge research, in this undated handout photo taken in Lausanne, Switzerland. He had been unable to move his legs for one year before he entered the project'. Image: NeuroRestore/Jimmy Ravier/Handout via REUTERS

A male scientist in white coat holding a test tube.

'A member of a research team who, as they say, have developed an implant of genetically engineered cells into the injured spinal cord of paralysed mice that has helped them walk again works at a laboratory at Tel Aviv University, Israel'. Image: REUTERS/Amir Cohen

Discover

How is the World Economic Forum bringing data-driven healthcare to life?

Have you read?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.